|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 245.78 USD | +0.23% |
|
-0.02% | +42.88% |
| Nov. 25 | Resmed Insider Sold Shares Worth $1,497,416, According to a Recent SEC Filing | MT |
| Nov. 13 | ResMed Inc. Presents at UBS Global Healthcare Conference 2024, Nov-12-2024 03:30 PM |
| Capitalization | 36.07B 34.4B 31.89B 28.29B 51B 3,058B 56.65B 396B 147B 1,258B 135B 132B 5,500B | P/E ratio 2025 * |
27.3x | P/E ratio 2026 * | 24.7x |
|---|---|---|---|---|---|
| Enterprise value | 35.74B 34.08B 31.6B 28.03B 50.53B 3,030B 56.13B 393B 145B 1,246B 134B 131B 5,449B | EV / Sales 2025 * |
6.99x | EV / Sales 2026 * | 6.34x |
| Free-Float |
76.79% | Yield 2025 * |
0.89% | Yield 2026 * | 1.01% |
More valuation ratios
* Estimated data
More news
Last Transcript: ResMed, Inc.
More recommendations
More press releases
| 1 day | +0.31% | ||
| 1 week | -0.02% | ||
| Current month | -1.30% | ||
| 1 month | -1.17% | ||
| 3 months | -2.82% | ||
| 6 months | +16.94% | ||
| Current year | +42.88% |
1 week
239.41
247.76
1 month
231.17252.36
Current year
164.12260.49
1 year
164.12260.49
3 years
132.24264.53
5 years
108.85301.34
10 years
48.99301.34
| Director | Title | Age | Since |
|---|---|---|---|
Mick Farrell
CEO | Chief Executive Officer | 51 | 2013-02-28 |
Brett Sandercock
DFI | Director of Finance/CFO | 57 | 2005-12-31 |
Jim Ellis
CMP | Compliance Officer | - | 2017-12-31 |
| Manager | Title | Age | Since |
|---|---|---|---|
Rich Sulpizio
BRD | Director/Board Member | 74 | 2005-08-24 |
Ron Taylor
BRD | Director/Board Member | 76 | 2004-12-31 |
Mick Farrell
CHM | Chairman | 51 | 2023-01-24 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.09% | 20 M€ | +16.68% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +0.23% | -0.02% | +50.29% | -5.97% | 36.07B | ||
| -0.28% | +1.04% | +7.95% | -16.83% | 204B | ||
| +1.02% | -1.15% | +72.34% | +57.58% | 194B | ||
| +0.45% | -0.36% | +6.35% | -25.86% | 170B | ||
| +0.40% | -0.31% | +63.88% | +119.97% | 133B | ||
| -0.35% | +4.29% | +2.70% | -18.86% | 63.49B | ||
| -0.26% | +1.06% | -11.93% | -29.22% | 43.69B | ||
| +0.57% | -0.53% | +4.98% | -39.42% | 43.53B | ||
| -0.52% | +0.71% | +9.48% | -9.64% | 40.27B | ||
| +0.47% | -0.31% | +16.34% | - | 37.81B | ||
| Average | +0.26% | +0.34% | +22.24% | +3.53% | 96.64B | |
| Weighted average by Cap. | +0.39% | -0.14% | +28.89% | +15.65% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 5.12B 4.88B 4.52B 4.01B 7.23B 434B 8.04B 56.21B 20.81B 178B 19.22B 18.79B 780B | 5.49B 5.24B 4.86B 4.31B 7.77B 466B 8.63B 60.35B 22.35B 192B 20.64B 20.18B 838B |
| Net income | 1.33B 1.27B 1.17B 1.04B 1.88B 113B 2.09B 14.59B 5.4B 46.3B 4.99B 4.88B 202B | 1.47B 1.4B 1.3B 1.15B 2.08B 125B 2.31B 16.16B 5.98B 51.28B 5.52B 5.4B 224B |
| Net Debt | -330M -315M -292M -259M -466M -27.97B -518M -3.62B -1.34B -11.5B -1.24B -1.21B -50.3B | -1.23B -1.18B -1.09B -969M -1.75B -105B -1.94B -13.56B -5.02B -43.05B -4.64B -4.54B -188B |
More financial data
* Estimated data
Employees
9,980
Calendar
2025-01-22
- Q2 2025 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-12-11 | 245.78 $ | +0.23% | 514,234 |
| 24-12-10 | 245.22 $ | +0.19% | 505,873 |
| 24-12-09 | 244.76 $ | +1.39% | 583,582 |
| 24-12-06 | 241.41 $ | +0.84% | 462,436 |
| 24-12-05 | 239.41 $ | -2.62% | 642,392 |
Delayed Quote Nyse, December 11, 2024 at 04:00 pm EST
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
245.78USD
Average target price
253.39USD
Spread / Average Target
+3.10%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- RMD Stock